Weight Loss Stacks
Fat Loss & Recomposition
Peptide combinations for fat loss, appetite management, and body recomposition.
Retatrutide Protocol
AdvancedGLP-1/GIP/glucagon triple agonist. Latest-generation breakthrough with strong clinical data for weight loss. Often used standalone; titration per provider.
Semaglutide + Tesamorelin
AdvancedPowerful appetite suppression via GLP-1 combined with visceral fat targeting through GHRH. Comprehensive approach to stubborn body fat.
GLP-1 + AOD-9604
BeginnerGLP-1 appetite control paired with HGH fragment for fat metabolism. AOD-9604 targets lipolysis without GH-related side effects.
Tirzepatide Protocol
IntermediateDual GLP-1/GIP agonist protocol. Often used standalone due to potency. Detailed titration schedule and management strategies.
Recomposition Stack
AdvancedFat loss with muscle preservation. GLP-1 for caloric reduction plus GH optimization to maintain lean mass during deficit.
Weight Loss Stack Principles
- Effective weight loss stacks typically combine compounds that address different aspects of the fat loss equation.
- Common mechanisms targeted:
- • Metabolic support (GH peptides) — Maintain muscle mass and metabolic rate
- • Visceral fat targeting (Tesamorelin) — Specifically reduce dangerous abdominal fat
- • Fat mobilization (AOD-9604, HGH frag) — Enhance lipolysis and fatty acid release
- • Appetite suppression (GLP-1 agonists) — Reduce caloric intake through satiety signaling
Key considerations
- •Some compounds (Semaglutide, Tirzepatide) are FDA-approved for obesity
- •Nutrition and exercise remain foundational — peptides enhance, not replace
- •Rapid weight loss without GH support can result in muscle loss
- •GLP-1 agonists require careful titration to manage GI side effects
Educational only. Confirm stacking with your provider.